A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Smith & Nephew PLC stock. As of the latest transaction made, Bridgewater Associates, LP holds 63,039 shares of SNN stock, worth $1.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
63,039
Previous 59,891 5.26%
Holding current value
$1.6 Million
Previous $1.63 Million 2.14%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$25.36 - $28.88 $79,833 - $90,914
3,148 Added 5.26%
63,039 $1.6 Million
Q4 2023

Feb 14, 2024

SELL
$21.55 - $27.43 $226,231 - $287,960
-10,498 Reduced 14.91%
59,891 $1.63 Million
Q3 2023

Nov 13, 2023

SELL
$24.33 - $31.28 $164,105 - $210,983
-6,745 Reduced 8.74%
70,389 $1.74 Million
Q2 2023

Aug 11, 2023

SELL
$28.08 - $32.7 $612,087 - $712,794
-21,798 Reduced 22.03%
77,134 $2.49 Million
Q1 2023

May 12, 2023

SELL
$27.29 - $29.4 $2.44 Million - $2.62 Million
-89,260 Reduced 47.43%
98,932 $2.76 Million
Q4 2022

Feb 13, 2023

BUY
$22.3 - $27.91 $850,410 - $1.06 Million
38,135 Added 25.41%
188,192 $5.06 Million
Q3 2022

Nov 10, 2022

BUY
$12.1 - $29.35 $329,216 - $798,554
27,208 Added 22.15%
150,057 $3.48 Million
Q2 2022

Aug 11, 2022

SELL
$27.53 - $33.71 $226,186 - $276,961
-8,216 Reduced 6.27%
122,849 $3.43 Million
Q1 2022

May 13, 2022

BUY
$30.84 - $36.38 $423,032 - $499,024
13,717 Added 11.69%
131,065 $4.18 Million
Q4 2021

Feb 14, 2022

BUY
$31.98 - $37.15 $1.13 Million - $1.31 Million
35,225 Added 42.89%
117,348 $4.06 Million
Q3 2021

Nov 12, 2021

BUY
$34.34 - $44.17 $1.17 Million - $1.5 Million
34,036 Added 70.78%
82,123 $2.82 Million
Q2 2021

Aug 13, 2021

BUY
$37.86 - $44.01 $1.82 Million - $2.12 Million
48,087 New
48,087 $2.09 Million

Others Institutions Holding SNN

About SMITH & NEPHEW PLC


  • Ticker SNN
  • Exchange OTC
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 435,348,000
  • Market Cap $11B
  • Description
  • Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabi...
More about SNN
Track Ray Dalio's Portfolio

Track Ray Dalio Portfolio

Follow Ray Dalio (Bridgewater Associates, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.